A Phase 1, Single-Center, Open-Label, Induction Dose Study of ABP-700 in Healthy, Adult Subjects

Trial Profile

A Phase 1, Single-Center, Open-Label, Induction Dose Study of ABP-700 in Healthy, Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Fentanyl (Primary) ; MDCO 700 (Primary) ; Midazolam (Primary)
  • Indications Anaesthesia
  • Focus Adverse reactions
  • Sponsors The Medicines Company
  • Most Recent Events

    • 13 Oct 2016 According to The Medicines Company media release, data from this trial will be presented at the International Society for Anaesthetic Pharmacology 25th Annual Meeting (ISAP) 2016.
    • 14 Jun 2016 Status changed from recruiting to completed, according to The Medicines Company media release.
    • 24 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top